A CTSA Agenda to Advance Methods for Comparative Effectiveness Research
Article first published online: 27 JUN 2011
© 2011 Wiley Periodicals, Inc.
Clinical and Translational Science
Volume 4, Issue 3, pages 188–198, June 2011
How to Cite
Helfand, M., Tunis, S., Whitlock, E. P., Pauker, S. G., Basu, A., Chilingerian, J., Harrell Jr., F. E., Meltzer, D. O., Montori, V. M., Shepard, D. S., Kent, D. M. and The Methods Work Group of the National CTSA Strategic Goal Committee on Comparative Effectiveness Research (2011), A CTSA Agenda to Advance Methods for Comparative Effectiveness Research. Clinical and Translational Science, 4: 188–198. doi: 10.1111/j.1752-8062.2011.00282.x
- Issue published online: 27 JUN 2011
- Article first published online: 27 JUN 2011
- patient-centered outcomes research;
- translational science;
- comparative effectiveness;
- clinical research methods
Clinical research needs to be more useful to patients, clinicians, and other decision makers. To meet this need, more research should focus on patient-centered outcomes, compare viable alternatives, and be responsive to individual patients’ preferences, needs, pathobiology, settings, and values. These features, which make comparative effectiveness research (CER) fundamentally patient-centered, challenge researchers to adopt or develop methods that improve the timeliness, relevance, and practical application of clinical studies.
In this paper, we describe 10 priority areas that address 3 critical needs for research on patient-centered outcomes (PCOR): (1) developing and testing trustworthy methods to identify and prioritize important questions for research; (2) improving the design, conduct, and analysis of clinical research studies; and (3) linking the process and outcomes of actual practice to priorities for research on patient-centered outcomes. We argue that the National Institutes of Health, through its clinical and translational research program, should accelerate the development and refinement of methods for CER by linking a program of methods research to the broader portfolio of large, prospective clinical and health system studies it supports. Insights generated by this work should be of enormous value to PCORI and to the broad range of organizations that will be funding and implementing CER. Clin Trans Sci 2011; Volume 4: 188–198